Table 1 Summary of patient characteristics
Patient characteristics | |||
|---|---|---|---|
biometric | (years) | (range) | |
median age | 51 | 10 - 88 | |
(n) | (%) | ||
female | 33 | 36 | |
male | 59 | 64 | |
Initial symtoms | (n) | (%) | |
asymptomatic | 18 | 20 | |
pituitary subfunction | 2 | 2 | |
hormonal excess | 29 | 32 | |
reduced visual field / acuity | 29 | 32 | |
cerebral symptoms (headache, nausea, neuropsycholgical) | 14 | 15 | |
histology | (n) | (%) | |
non-secreting | 55 | 60 | |
GH-secreting | 22 | 24 | |
Prolactine-secreting | 8 | 9 | |
ACTH-secreting | 6 | 7 | |
TSH-secreting | 1 | 1 | |
(n) | (%) | ||
surgery | any | 87 | |
complete | 35 | 38 | |
incomplete | 52 | 57 | |
(n) | (%) | ||
re-surgery | any | 48 | |
complete | 8 | 9 | |
incomplete | 40 | 44 | |
(n) | (%) | ||
radiotherapy | 3D conformal | 15 | |
FSRT | 76 | 83 | |
IMRT | 1 | 1 | |
(Gy) | (range) | ||
median single dose | 1.8 | 1.8 – 2.0 | |
median total dose | 52.2 | 48.6 – 58.0 | |
(n) | (%) | ||
primary definitive RT | 5 | 5 | |
postoperative RT | 15 | 16 | |
RT for recurrent tumors | 72 | 78 | |